Role of the sodium-hydrogen exchanger in mediating the renal effects of drugs commonly used in the treatment of type 2 diabetes
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of the sodium-hydrogen exchanger in mediating the renal effects of drugs commonly used in the treatment of type 2 diabetes
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 20, Issue 4, Pages 800-811
Publisher
Wiley
Online
2017-12-11
DOI
10.1111/dom.13191
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure
- (2017) Milton Packer et al. LANCET
- Phosphorylation of NHE3-S719 regulates NHE3 activity through the formation of multiple signaling complexes
- (2017) Rafiquel Sarker et al. MOLECULAR BIOLOGY OF THE CELL
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Renal Outcomes in Type 2 Diabetes
- (2017) Johannes F.E. Mann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes
- (2017) Shin Kawasoe et al. BMC Pharmacology & Toxicology
- Effects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure
- (2017) Milton Packer et al. JAMA Cardiology
- Targeting gene expression to specific cells of kidney tubules in vivo, using adenoviral promoter fragments
- (2017) Sumiyo Watanabe et al. PLoS One
- Novel developments in differentiating the role of renal and intestinal sodium hydrogen exchanger 3
- (2016) Jessica A. Dominguez Rieg et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome
- (2016) Hiroaki Kusaka et al. Cardiovascular Diabetology
- Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
- (2016) Hiddo J.L. Heerspink et al. CIRCULATION
- Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection FractionCLINICAL PERSPECTIVE
- (2016) Søren L. Kristensen et al. Circulation-Heart Failure
- Blood pressure-independent renoprotection in diabetic rats treated with AT1 receptor-neprilysin inhibition compared with AT1 receptor blockade alone
- (2016) L. C. W. Roksnoer et al. CLINICAL SCIENCE
- Reappraisal of the diuretic effect of empagliflozin in the EMPA-REG OUTCOME trial: Comparison with classic diuretics
- (2016) A.J. Scheen DIABETES & METABOLISM
- Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial
- (2016) Ofri Mosenzon et al. DIABETES CARE
- Addition of a dipeptidyl peptidase-4 inhibitor, sitagliptin, to ongoing therapy with the glucagon-like peptide-1 receptor agonist liraglutide: A randomized controlled trial in patients with type 2 diabetes
- (2016) Michael A. Nauck et al. DIABETES OBESITY & METABOLISM
- The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes
- (2016) David Cherney et al. DIABETOLOGIA
- Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition
- (2016) Volker Vallon et al. DIABETOLOGIA
- SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
- (2016) Naveed Sattar et al. DIABETOLOGIA
- Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
- (2016) Antonius Baartscheer et al. DIABETOLOGIA
- Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME®trial
- (2016) David Fitchett et al. EUROPEAN HEART JOURNAL
- Effects of Sacubitril/Valsartan (LCZ696) on Natriuresis, Diuresis, Blood Pressures, and NT-proBNP in Salt-Sensitive HypertensionNovelty and Significance
- (2016) Tzung-Dau Wang et al. HYPERTENSION
- Effects of dipeptidyl peptidase-4 inhibitors on blood pressure in patients with type 2 diabetes
- (2016) Xiaodan Zhang et al. JOURNAL OF HYPERTENSION
- Significant natriuretic and antihypertensive action of the epithelial sodium channel blocker amiloride in diabetic patients with and without nephropathy
- (2016) Henrik Andersen et al. JOURNAL OF HYPERTENSION
- Incretin-Based Therapy for Diabetes
- (2016) Greer Waldrop et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2
- (2016) Michael J. Coady et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Protection against death and renal failure by renin-angiotensin system blockers in patients with diabetes and kidney disease
- (2016) J. Shen et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Stromal cell–derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy
- (2016) Satoru Takashima et al. KIDNEY INTERNATIONAL
- Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials
- (2016) Xue Shen et al. Lipids in Health and Disease
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and Renal Outcomes of Renin–Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses
- (2016) Ferrán Catalá-López et al. PLOS MEDICINE
- Inhibition of NA+/H+Exchanger 1 Attenuates Renal Dysfunction Induced by Advanced Glycation End Products in Rats
- (2016) Peng Li et al. Journal of Diabetes Research
- Greater efficacy of atorvastatin versus a non-statin lipid-lowering agent against renal injury: potential role as a histone deacetylase inhibitor
- (2016) Ravi Shankar Singh et al. Scientific Reports
- Mechanisms for the cardiovascular effects of glucagon-like peptide-1
- (2015) H. Poudyal Acta Physiologica
- DPP4 in Cardiometabolic Disease: Recent Insights From the Laboratory and Clinical Trials of DPP4 Inhibition
- (2015) J. Zhong et al. CIRCULATION RESEARCH
- Angiotensin-(1–7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice
- (2015) Yixuan Shi et al. CLINICAL SCIENCE
- Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction
- (2015) Adriaan A. Voors et al. EUROPEAN JOURNAL OF HEART FAILURE
- Na+/H+ exchanger in the regulation of platelet activation and paradoxical effects of cariporide
- (2015) He Benny Chang et al. EXPERIMENTAL NEUROLOGY
- Crosstalk between the renal sympathetic nerve and intrarenal angiotensin II modulates proximal tubular sodium reabsorption
- (2015) Roberto B. Pontes et al. EXPERIMENTAL PHYSIOLOGY
- AT2R Agonist, Compound 21, Is Reno-Protective Against Type 1 Diabetic Nephropathy
- (2015) C. Koulis et al. HYPERTENSION
- Physiological Functions and Regulation of the Na+/H+ Exchanger [NHE1] in Renal Tubule Epithelial Cells
- (2015) Patricia G Vallés et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Angiotensin(1–7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade
- (2015) Kai Zhang et al. KIDNEY INTERNATIONAL
- Sorting nexin 27 regulates basal and stimulated brush border trafficking of NHE3
- (2015) Varsha Singh et al. MOLECULAR BIOLOGY OF THE CELL
- Spironolactone inhibits podocyte motility via decreasing integrin β1 and increasing integrin β3 in podocytes under high-glucose conditions
- (2015) ZHUO LI et al. Molecular Medicine Reports
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
- (2015) Jose Górriz et al. Journal of Clinical Medicine
- The Na+/H+ Exchanger-3 (NHE3) Activity Requires Ezrin Binding to Phosphoinositide and Its Phosphorylation
- (2015) Victor Babich et al. PLoS One
- Meta-Analysis of the Effect of Statins on Renal Function
- (2014) Qiang Geng et al. AMERICAN JOURNAL OF CARDIOLOGY
- Sodium/Glucose Cotransporter 2 Inhibitors and Prevention of Diabetic Nephropathy: Targeting the Renal Tubule in Diabetes
- (2014) Luca De Nicola et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial
- (2014) Benjamin M. Scirica et al. CIRCULATION
- Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone
- (2014) T. Forst et al. DIABETES OBESITY & METABOLISM
- Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment
- (2014) B. J. von Scholten et al. DIABETIC MEDICINE
- Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism
- (2014) Suxian Zhou et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats
- (2014) Amal Hofni et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Intestinal regulation of urinary sodium excretion and the pathophysiology of diabetic kidney disease: a focus on glucagon-like peptide 1 and dipeptidyl peptidase 4
- (2014) Volker Vallon et al. EXPERIMENTAL PHYSIOLOGY
- Cyclic GMP Kinase II (cGKII) Inhibits NHE3 by Altering Its Trafficking and Phosphorylating NHE3 at Three Required Sites
- (2014) Tiane Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effect of Canagliflozin on Blood Pressure and Adverse Events Related to Osmotic Diuresis and Reduced Intravascular Volume in Patients With Type 2 Diabetes Mellitus
- (2014) Matthew R. Weir et al. Journal of Clinical Hypertension
- Amiloride lowers blood pressure and attenuates urine plasminogen activation in patients with treatment–resistant hypertension
- (2014) Christina S. Oxlund et al. Journal of the American Society of Hypertension
- Functional Role of Glucose Metabolism, Osmotic Stress, and Sodium-Glucose Cotransporter Isoform-Mediated Transport on Na+/H+ Exchanger Isoform 3 Activity in the Renal Proximal Tubule
- (2014) T. D. Pessoa et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Novel mechanism of intra-renal angiotensin II-induced sodium/proton exchanger 3 expression by losartan in spontaneously hypertensive rats
- (2014) XIAOQIN FAN et al. Molecular Medicine Reports
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dipeptidyl peptidase-4 inhibitors and heart failure: A meta-analysis of randomized clinical trials
- (2014) M. Monami et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice
- (2014) Naoto Terami et al. PLoS One
- Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy
- (2013) Yan-Ming Sun et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Activation of Angiotensin Type 2 Receptors Partially Ameliorates Streptozotocin-Induced Diabetes in Male Rats by Islet Protection
- (2013) Chunhong Shao et al. ENDOCRINOLOGY
- Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: An emerging paradigm in diabetic nephropathy
- (2013) Thomas A. Mavrakanas et al. European Journal of Internal Medicine
- The regulation of NHE1 and NHE3 activity by angiotensin II is mediated by the activation of the angiotensin II type I receptor/phospholipase C/calcium/calmodulin pathway in distal nephron cells
- (2013) Juliana Martins da Costa-Pessoa et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?
- (2013) Dragana Nikolic et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Antihypertensive Effects of Statins: A Meta-Analysis of Prospective Controlled Studies
- (2013) Alexandros Briasoulis et al. Journal of Clinical Hypertension
- Proximal tubule specific knockout of the Na+/H+ exchanger NHE3: effects on bicarbonate absorption and ammonium excretion
- (2013) Hong C. Li et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Roles of Na+/H+ Exchanger Type 1 and Intracellular pH in Angiotensin II-Induced Reactive Oxygen Species Generation and Podocyte Apoptosis
- (2013) Ya Liu et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control
- (2013) Donald E. Kohan et al. KIDNEY INTERNATIONAL
- The gut–renal axis: do incretin-based agents confer renoprotection in diabetes?
- (2013) Marcel H. A. Muskiet et al. Nature Reviews Nephrology
- Acid loading stimulates rat glomerular mesangial cells proliferation through Na+–H+ exchanger isoform 1 (NHE1)-dependent pathway
- (2013) Kun Li et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thiazolidinedione-Induced Fluid Retention: Recent Insights into the Molecular Mechanisms
- (2013) Jerzy Bełtowski et al. PPAR Research
- Role of the Na+/H+ exchanger on the development of diabetes mellitus and its chronic complications
- (2012) Yan-Ming Sun et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy
- (2012) J. Rosenstock et al. DIABETES CARE
- Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience
- (2012) D. E. Bonds et al. DIABETOLOGIA
- Antihypertensive and Laxative Effects by Pharmacological Inhibition of Sodium-Proton-Exchanger Subtype 3–Mediated Sodium Absorption in the Gut
- (2012) Dominik Linz et al. HYPERTENSION
- DPP-4 Inhibition on Top of Angiotensin Receptor Blockade Offers a New Therapeutic Approach for Diabetic Nephropathy
- (2012) Markus L. Alter et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Atorvastatin improves sodium handling and decreases blood pressure in salt-loaded rats with chronic renal insufficiency
- (2012) Luis I. Juncos et al. NUTRITION
- Dapagliflozin: A Novel Sodium-Glucose Cotransporter Type 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
- (2012) Niren K. Shah et al. PHARMACOTHERAPY
- Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat
- (2011) Scott C. Thomson et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Thiazolidinediones Enhance Sodium-Coupled Bicarbonate Absorption from Renal Proximal Tubules via PPARγ-Dependent Nongenomic Signaling
- (2011) Yoko Endo et al. Cell Metabolism
- Renal Function in Type 2 Diabetes with Rosiglitazone, Metformin, and Glyburide Monotherapy
- (2011) J. M. Lachin et al. Clinical Journal of the American Society of Nephrology
- Non-invited Review: Prevention of microvascular diabetic complications by fenofibrate: lessons from FIELD and ACCORD
- (2011) Michel P Hermans Diabetes & Vascular Disease Research
- Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
- (2011) R. Kodera et al. DIABETOLOGIA
- Long-term mineralocorticoid receptor blockade ameliorates progression of experimental diabetic renal disease
- (2011) M. Lian et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- PPAR 2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies
- (2011) S. De Cosmo et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production
- (2011) J. Toyonaga et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Body Fluid Volumes and the Response of Renin and Aldosterone to Short- and Long-Term Thiazide Therapy of Essential Hypertension
- (2010) P. Brummelen et al. ACTA MEDICA SCANDINAVICA
- Mechanisms of proximal tubule sodium transport regulation that link extracellular fluid volume and blood pressure
- (2010) Alicia A. McDonough AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Regulation of Na+/H+ Exchanger Isoform 1 (NHE1) by Calmodulin-binding Sites: Role of Angiotensin II
- (2010) Débora Mai N. Eguti et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Drug-Induced Changes in Risk/Biomarkers and Their Relationship with Renal and Cardiovascular Long-Term Outcome in Patients with Diabetes
- (2010) Y. Miao et al. CLINICAL CHEMISTRY
- Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes: A prospective randomized double-blind clinical trial
- (2010) P. Ruggenenti et al. DIABETES CARE
- Activation of Na+/H+Exchanger NHE3 by Angiotensin II Is Mediated by Inositol 1,4,5-Triphosphate (IP3) Receptor-binding Protein Released with IP3(IRBIT) and Ca2+/Calmodulin-dependent Protein Kinase II
- (2010) Peijian He et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Acute Effects of Atorvastatin on Glomerular Filtration Rate, Tubular Function, Blood Pressure, and Vasoactive Hormones in Patients With Type 2 Diabetes
- (2010) L. Paulsen et al. JOURNAL OF CLINICAL PHARMACOLOGY
- SGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubule
- (2010) V. Vallon et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
- (2010) Faramarz Ismail-Beigi et al. LANCET
- Effect of Ramipril Alone Compared to Ramipril with Eplerenone on Diabetic Nephropathy in Streptozocin-Induced Diabetic Rats
- (2010) Thomas A. Mavrakanas et al. PHARMACOLOGY
- Aldosterone Promotes Fibronectin Synthesis in Rat Mesangial Cells via ERK1/2-Stimulated Na+-H+ Exchanger Isoform 1
- (2009) Minmin Zhang et al. AMERICAN JOURNAL OF NEPHROLOGY
- Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
- (2009) G. Y. Oudit et al. DIABETES
- Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial
- (2009) S. Zoungas et al. DIABETES CARE
- NHE3 regulatory complexes
- (2009) M. Donowitz et al. JOURNAL OF EXPERIMENTAL BIOLOGY
- Mineralocorticoid Receptor Blockade Enhances the Antiproteinuric Effect of an Angiotensin II Blocker through Inhibiting Podocyte Injury in Type 2 Diabetic Rats
- (2009) A. Nishiyama et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The Role of Na+-H+Exchanger Isoform 1 in Aldosterone-Induced Glomerulosclerosis in Vivo
- (2009) Minmin Zhang et al. RENAL FAILURE
- Expression of ACE and ACE2 in Individuals With Diabetic Kidney Disease and Healthy Controls
- (2008) Sonoo Mizuiri et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Spironolactone exhibits direct renoprotective effects and inhibits renal renin–angiotensin–aldosterone system in diabetic rats
- (2008) Masateru Taira et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease
- (2008) Heather N. Reich et al. KIDNEY INTERNATIONAL
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
- (2008) LANCET
- Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats
- (2008) Y. S. Kang et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The role of SGK-1 in angiotensin II-mediated sodium reabsorption in human proximal tubular cells
- (2008) V. A Stevens et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The role of Sgk-1 in the upregulation of transport proteins by PPAR- agonists in human proximal tubule cells
- (2008) S. Saad et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
- (2008) William Duckworth et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Effects of Spironolactone on Nephron Function in Patients with Diabetic Nephropathy
- (2008) Ayten Ustundag et al. RENAL FAILURE
- Effects of statins on renal sodium and water handling: Acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans
- (2007) L. Paulsen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started